+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis Report by Phase (Preclinical, Clinical), by Test Type (ADME, PD), by End-user, by Type, by Therapeutic Areas, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 137 Pages
  • September 2022
  • Region: Global
  • Grand View Research
  • ID: 5406436
The global large molecule bioanalytical testing services market size is expected to reach USD 3.5 billion by 2030, registering a CAGR of 9.1% over the forecast period. The increased use of bioanalytical testing in clinical trials of biomarkers, large molecules, and other substances is the main driver of the industry. The rising incidence of chronic diseases and the rising demand for clinical trials in developing nations are the factors driving the market growth. For instance, according to the WHO, around 10 million people died from cancer in 2020. As per the estimates of cancer, 30.2 million people are likely to have cancer by 2040. Other factors that are anticipated to drive the segment growth include a rise in biologics, high demand for advanced technologies, and the need for personalized orphan drugs & medicines.

It is also projected that factors like technological advancement, globalization of clinical trials, and the rising need for CROs to perform clinical trials will accelerate industry expansion. Large pharmaceutical and bioanalytical firms, however, encountered difficulties as a result of the COVID-19 pandemic, which hampered clinical studies and treatments. Along with the workload of the COVID-19 project, which involves starting clinical trials, preclinical testing, doing bioanalysis, and interacting with regulatory bodies, other difficulties include the loss of workers at sites. The non-Covid initiatives were delayed, and there were lengthy 4-6 month wait times as a result of the resources being used to support the bioanalytical, preclinical, and clinical testing for the Covid trials. They must also resolve assays that are related to Covid and those that are not.

Large Molecule Bioanalytical Testing Services Market Report Highlights

  • The clinical segment dominated the global industry in 2021. The growing prevalence of chronic diseases and increasing demand for clinical trials in developing countries are factors expected to drive segment growth
  • The ADA-type segment dominated the global industry in 2021 and accounted for the largest share of the overall revenue
  • Bioavailability was the largest test segment share in 2021 on account of the increasing adoption in generic drug manufacturing
  • The oncology segment held the largest revenue share in 2021 due to the increasing prevalence of cancer globally
  • Asia Pacific is projected to witness the fastest CAGR during the forecast years due to the rising healthcare expenditure, particularly in India and China


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Phase
1.1.2. Type
1.1.3. Test Type
1.1.4. Therapeutic Areas
1.1.5. End User
1.1.6. Regional scope
1.1.7. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
Chapter 3. Large Molecule Bioanalytical Testing Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing focus on the analytical testing
3.3.1.2. Growing R & D expenditure in the pharmaceutical and biopharmaceutical industries
3.3.1.3. Rising demand for outsourcing of analytical testing
3.3.2. Market restraint analysis
3.3.2.1. Compliance issues while outsourcing
3.4. Large Molecule Bioanalytical Testing Services Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.2. PESTEL Analysis
3.4.3. Market Entry Strategies
3.5. COVID - 19 Impact Analysis
3.5.1. COVID - 19 recovery analysis
3.6. Major Deals & Strategic Alliances Analysis
Chapter 4. Large Molecule Bioanalytical Testing Services Market: Phase Estimates & Trend Analysis
4.1. Definitions and Scope
4.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
4.3. Segment Dashboard
4.4. Global Large Molecule Bioanalytical Testing Services Market by Phase Outlook
4.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Preclinical
4.5.1.1. Preclinical market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.2. With Antibody
4.5.1.2.1. With Antibody market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.3. Without Antibody ((ELISA Based Assay)
4.5.1.3.1. Without Antibody (ELISA Based Assay) market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Clinical
4.5.2.1. Clinical market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Large Molecule Bioanalytical Testing Services Market by Type Estimates & Trend Analysis
5.1. Definitions and Scope
5.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
5.3. Segment Dashboard
5.4. Global Large Molecule Bioanalytical Testing Services Market by Type Outlook
5.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Pharmacokinetics
5.5.1.1. Pharmacokinetics market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. ADA
5.5.2.1. ADA market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Others
5.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Large Molecule Bioanalytical Testing Services Market: Test Type Estimates & Trend Analysis
6.1. Definitions and Scope
6.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
6.3. Segment Dashboard
6.4. Global Large Molecule Bioanalytical Testing Services Market by Test Type Outlook
6.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. ADME
6.5.1.1. ADME market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. PD
6.5.2.1. PD market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Bioavailability
6.5.3.1. Bioavailability market estimates and forecast 2018 to 2030 (USD Million)
6.5.4. Bioequivalence
6.5.4.1. Bioequivalence market estimates and forecast 2018 to 2030 (USD Million)
6.5.5. Other Tests
6.5.5.1. Other Tests market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas Estimates & Trend Analysis
7.1. Definitions and Scope
7.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
7.3. Segment Dashboard
7.4. Global Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas Outlook
7.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5.1. Oncology
7.5.1.1. Oncology market estimates and forecast 2018 to 2030 (USD Million)
7.5.2. Infectious Diseases
7.5.2.1. Infectious Diseases market estimates and forecast 2018 to 2030 (USD Million)
7.5.3. Cardiology
7.5.3.1. Cardiology market estimates and forecast 2018 to 2030 (USD Million)
7.5.4. Neurology
7.5.4.1. Neurology market estimates and forecast 2018 to 2030 (USD Million)
7.5.5. Others
7.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 8. Large Molecule Bioanalytical Testing Services Market by End - user Estimates & Trend Analysis
8.1. Definitions and Scope
8.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
8.3. Segment Dashboard
8.4. Global Large Molecule Bioanalytical Testing Services Market by End User Outlook
8.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5.1. SMEs
8.5.1.1. SMEs market estimates and forecast 2018 to 2030 (USD Million)
8.5.1.2. CROs & CMOs
8.5.1.2.1. CROs & CMOs market estimates and forecast 2018 to 2030 (USD Million)
8.5.1.3. Sponsor Organizations
8.5.1.3.1. Sponsor Organizations market estimates and forecast 2018 to 2030 (USD Million)
8.5.1.4. Others
8.5.1.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
8.5.2. Large Firms
8.5.2.1. Large Firms market estimates and forecast 2018 to 2030 (USD Million)
8.5.2.2. CROs & CMOs
8.5.2.2.1. CROs & CMOs market estimates and forecast 2018 to 2030 (USD Million)
8.5.2.3. Sponsor Organizations
8.5.2.3.1. Sponsor Organizations market estimates and forecast 2018 to 2030 (USD Million)
8.5.2.4. Others
8.5.2.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 9. Large Molecule Bioanalytical Testing Services Market: Regional Estimates & Trend Analysis
9.1. Regional market share analysis, 2021 & 2030
9.2. Regional Market Dashboard
9.3. North America
9.3.1. North America Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.3.2. U.S.
9.3.2.1. U.S. Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.3.3. Canada
9.3.3.1. Canada Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.4. Europe
9.4.1. U.K.
9.4.1.1. U.K. Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.4.2. Germany
9.4.2.1. Germany Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.4.3. France
9.4.3.1. France Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.4.4. Italy
9.4.4.1. Italy Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.4.5. Spain
9.4.5.1. Spain Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.5. Asia Pacific
9.5.1. Japan
9.5.1.1. Japan Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.5.2. China
9.5.2.1. China Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.5.3. India
9.5.3.1. India Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.5.4. Thailand
9.5.4.1. Thailand Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.5.5. South Korea
9.5.5.1. South Korea Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Brazil Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2. Mexico
9.6.2.1. Mexico Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3. Argentina
9.6.3.1. Argentina Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.6.4. Colombia
9.6.4.1. Colombia Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.7. MEA
9.7.1. South Africa
9.7.1.1. South Africa Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Saudi Arabia Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
9.7.3. UAE
9.7.3.1. UAE Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. 8.1 Recent Developments & Impact Analysis, By Key Market Participants
10.1.1. Covance
10.1.1.1. Company overview
10.1.1.2. Financial Performance
10.1.1.3. Service benchmarking
10.1.1.4. Strategic initiatives
10.1.2. IQVIA
10.1.2.1. Company overview
10.1.2.2. Financial performance
10.1.2.3. Service benchmarking
10.1.2.4. Strategic initiatives
10.1.3. Syneous Health
10.1.3.1. Company overview
10.1.3.2. Financial performance
10.1.3.3. Service benchmarking
10.1.3.4. Strategic initiatives
10.1.4. SGS, SA
10.1.4.1. Company overview
10.1.4.2. Financial performance
10.1.4.3. Service benchmarking
10.1.4.4. Strategic initiatives
10.1.5. Toxikon
10.1.5.1. Company overview
10.1.5.2. Financial performance
10.1.5.3. Service benchmarking
10.1.5.4. Strategic initiatives
10.1.6. Intertek Plc
10.1.6.1. Company overview
10.1.6.2. Financial performance
10.1.6.3. Service benchmarking
10.1.6.4. Strategic initiatives
10.1.7. Pace Analytical Services LLC
10.1.7.1. Company overview
10.1.7.2. Financial performance
10.1.7.3. Service benchmarking
10.1.7.4. Strategic initiatives
10.1.8. ICON PLC
10.1.8.1. Company overview
10.1.8.2. Financial performance
10.1.8.3. Service benchmarking
10.1.8.4. Strategic initiatives
10.1.9. Charles River Laboratories
10.1.9.1. Company overview
10.1.9.2. Financial performance
10.1.9.3. Service benchmarking
10.1.9.4. Strategic initiatives
10.1.10. ThermoFisher Scientific
10.1.10.1. Company overview
10.1.10.2. Financial performance
10.1.10.3. Service benchmarking
10.1.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Volume price analysis
Fig. 9 Large molecule bioanalytical testing services market snapshot (2021)
Fig. 10 Large molecule bioanalytical testing services market segmentation
Fig. 11 Heat map analysis
Fig. 12 Parent market outlook
Fig. 13 Ancillary market outlook
Fig. 14 Penetration & growth prospect mapping
Fig. 15 Market driver relevance analysis (Current & future impact)
Fig. 16 Market restraint relevance analysis (Current & future impact)
Fig. 17 Porter’s five forces analysis
Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 19 Large molecule bioanalytical testing services market phase outlook: Segment dashboard
Fig. 20 Large molecule bioanalytical testing services market: Phase movement analysis
Fig. 21 Preclinical market, 2018 - 2030 (USD Million)
Fig. 22 With antibody market, 2018 - 2030 (USD Million)
Fig. 23 Without antibody market, 2018 - 2030 (USD Million)
Fig. 24 Clinical market, 2018 - 2030 (USD Million)
Fig. 25 Large molecule bioanalytical testing services market type outlook: Segment dashboard
Fig. 26 Large molecule bioanalytical testing services market: Type movement analysis
Fig. 27 Pharmacokinetics market, 2018 - 2030 (USD Million)
Fig. 28 Anti-Drug Antibodies (ADA) market, 2018 - 2030 (USD Million)
Fig. 29 Others market, 2018 - 2030 (USD Million)
Fig. 30 Large molecule bioanalytical testing services market test type outlook: Segment dashboard
Fig. 31 Large molecule bioanalytical testing services market: Test type movement analysis
Fig. 32 ADME testing market, 2018 - 2030 (USD Million)
Fig. 33 PD market, 2018 - 2030 (USD Million)
Fig. 34 Bioavailability market, 2018 - 2030 (USD Million)
Fig. 35 Bioequivalence market, 2018 - 2030 (USD Million)
Fig. 36 Other tests market, 2018 - 2030 (USD Million)
Fig. 37 Large molecule bioanalytical testing services market therapeutic area outlook: Segment dashboard
Fig. 38 Large molecule bioanalytical testing services market: Therapeutic area movement analysis
Fig. 39 Oncology market, 2018 - 2030 (USD Million)
Fig. 40 Infectious diseases market, 2018 - 2030 (USD Million)
Fig. 41 Cardiology market, 2018 - 2030 (USD Million)
Fig. 42 Neurology market, 2018 - 2030 (USD Million)
Fig. 43 Others market, 2018 - 2030 (USD Million)
Fig. 44 Large molecule bioanalytical testing services market end-user outlook: Segment dashboard
Fig. 45 Large molecule bioanalytical testing services market: End-User movement analysis
Fig. 46 SMEs market, 2018 - 2030 (USD Million)
Fig. 47 CROs & CMO market, 2018 - 2030 (USD Million)
Fig. 48 Sponsor organization market, 2018 - 2030 (USD Million)
Fig. 49 Others market, 2018 - 2030 (USD Million)
Fig. 50 Large firms market, 2018 - 2030 (USD Million)
Fig. 51 CROs & CMOs market, 2018 - 2030 (USD Million)
Fig. 52 Sponsor organizations market, 2018 - 2030 (USD Million)
Fig. 53 Others market, 2018 - 2030 (USD Million)
Fig. 54 Regional market: Key takeaways
Fig. 55 Large molecule bioanalytical testing services market: Regional movement analysis
Fig. 56 North America. market, 2018 - 2030 (USD Million)
Fig. 57 U.S. market, 2018 - 2030 (USD Million)
Fig. 58 Canada market, 2018 - 2030 (USD Million)
Fig. 59 Europe market, 2018 - 2030 (USD Million)
Fig. 60 U.K. market, 2018 - 2030 (USD Million)
Fig. 61 Germany market, 2018 - 2030 (USD Million)
Fig. 62 France market, 2018 - 2030 (USD Million)
Fig. 63 Italy market, 2018 - 2030 (USD Million)
Fig. 64 Spain market, 2018 - 2030 (USD Million)
Fig. 65 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 66 Japan market, 2018 - 2030 (USD Million)
Fig. 67 China market, 2018 - 2030 (USD Million)
Fig. 68 India market, 2018 - 2030 (USD Million)
Fig. 69 Thailand market, 2018 - 2030 (USD Million)
Fig. 70 South Korea market, 2018 - 2030 (USD Million)
Fig. 71 Latin America market, 2018 - 2030 (USD Million)
Fig. 72 Brazil market, 2018 - 2030 (USD Million)
Fig. 73 Mexico market, 2018 - 2030 (USD Million)
Fig. 74 Argentina market, 2018 - 2030 (USD Million)
Fig. 75 Colombia market, 2018 - 2030 (USD Million)
Fig. 76 MEA market, 2018 - 2030 (USD Million)
Fig. 77 South Africa market, 2018 - 2030 (USD Million)
Fig. 78 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 79 UAE market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Covance
  • Iqvia
  • Syneous Health
  • Sgs, Sa
  • Toxikon
  • Intertek plc
  • Pace Analytical Services LLC
  • Icon plc
  • Charles River Laboratories
  • Thermofisher Scientific

Methodology

Loading
LOADING...

Table Information